![](/img/cover-not-exists.png)
The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphoma
Grit Hutter, Malte Rieken, Alessandro Pastore, Oliver Weigert, Yvonne Zimmermann, Marc Weinkauf, Wolfgang Hiddemann, Martin DreylingVolume:
91
Language:
english
Pages:
10
DOI:
10.1007/s00277-011-1377-y
Date:
June, 2012
File:
PDF, 310 KB
english, 2012